The Society for Immunotherapy of Cancer (SITC) has the pleasure
of hosting a prestigious fireside chat featuring two distinguished
figures in the field of cancer and immuno-oncology: Kim Rathmell, MD, PhD, Director of the National
Cancer Institute (NCI) and Leisha
Emens, MD, PhD, SITC President. This event will take place
during SITC 2024, Saturday, Nov. 9,
at the George R. Brown Convention Center in Houston, TX and virtual.
MILWAUKEE, Wis., Aug. 13,
2024 /PRNewswire-PRWeb/ -- The Society for
Immunotherapy of Cancer (SITC) has the pleasure of hosting a
prestigious fireside chat featuring two distinguished figures in
the field of cancer and immuno-oncology: Kim Rathmell, MD, PhD, Director of the National
Cancer Institute (NCI) and Leisha
Emens, MD, PhD, SITC President. This event will take place
during SITC 2024, Saturday, Nov. 9,
at the George R. Brown Convention Center in Houston, TX and virtual.
"I am honored to host this important discussion with
Dr. Rathmell, Director of the National Cancer Institute, as
she shares insights from her extensive experience." - SITC
President Leisha Emens, MD, PhD
"This fireside chat presents an opportunity to discuss the
latest advancements and collaborative efforts in cancer research,"
said SITC President Leisha
Emens, MD, PhD. "I am honored to host this important
discussion with Dr. Rathmell as she shares insights from her
extensive experience".
Dr. Rathmell is an accomplished physician-scientist, from
treating patients with kidney cancer to conducting research that
has advanced how scientists understand the molecular and genetic
drivers of the disease. Her genomic studies have led to the
identification of new molecular biomarkers to help detect and treat
kidney cancers earlier. In addition to publishing hundreds of
scientific articles about her research studies, Dr. Rathmell has
also published on ethical issues such as cancer drug shortages and
conflicts of interest in scientific publishing. Beyond her research
interests, she is deeply committed to mentoring and developing the
next generation of physician–scientists.
The conversation between Dr. Emens and Dr. Rathmell will cover a
range of topics including expanding infrastructure for cellular
therapies, multi-stakeholder engagement and advice for female
scientific leaders. This exchange aims to provide valuable insights
and allow attendees to understand the NCI's future and its role in
ending the disease of cancer.
Visit http://www.sitcancer.org/2024 for the latest updates and
to register for SITC's 39th Annual Meeting & Pre-Conference
Programs, being held from Nov. 6–10, 2024, at the George R. Brown
Convention Center in Houston, TX.
Virtual participation is also available. Visit
http://www.sitcancer.org for more information on this event and
other SITC resources.
SITC 2024 attendees will:
- Participate in key scientific sessions
focused on a variety of basic-, translational- and clinical-focused
topics from leaders in the field
- Learn about cutting-edge research with
over 1,400 oral abstract presentations and poster
presentations
- Engage with industry representatives
and learn about the latest technological advances in our exhibit
hall
- Earn continuing education credits
- Connect with other SITC 2024 attendees
from around the world
About SITC
Established in 1984, the Society for Immunotherapy of Cancer
(SITC) is a nonprofit organization of medical professionals
dedicated to improving cancer patient outcomes by advancing the
development, science and application of cancer immunotherapy and
tumor immunology. SITC is comprised of influential basic and
translational scientists, practitioners, health care professionals,
government leaders and industry professionals around the globe.
Through educational initiatives that foster scientific exchange and
collaboration among leaders in the field, SITC aims to one day make
the word "cure" a reality for cancer patients everywhere. Learn
more about SITC, our educational offerings and other resources at
sitcancer.org and follow us on X, LinkedIn, and YouTube.
Media Contact
Thomas Martin, Society for
Immunotherapy of Cancer, 414-271-2456, tmartin@sitcancer.org,
www.sitcancer.org
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/sitc-announces-fireside-chat-with-dr-kim-rathmell-and-dr-leisha-emens-at-its-39th-annual-meeting-302221281.html
SOURCE Society for Immunotherapy of Cancer